Article Information
History
- December 16, 2024.
Article Versions
- Version 1 (June 28, 2024 - 13:07).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
REVISION SUMMARY
One of the authors name, Kouji H Harada, was corrected.
Author Information
- Yohei Mineharu1,2,3,*,
- Takahiko Kamata1,4,
- Mei Tomoto3,
- Noriaki Sato3,5,
- Yoshinori Tamada6,
- Takeshi Funaki1,
- Yuki Oichi1,7,
- Kouji H Harada8,
- Akio Koizumi9,
- Tetsuaki Kimura10,11,
- Ituro Inoue10,
- Yasushi Okuno2,3,12,
- Susumu Miyamoto13 and
- Yoshiki Arakawa1
- 1Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Kyoto 606-8507, Japan
- 2Department of Artificial Intelligence in Healthcare and Medicine, Kyoto University Graduate School of Medicine, Kyoto, Kyoto 606-8507, Japan
- 3Department of Biomedical Data Intelligence, Kyoto University Graduate School of Medicine, Kyoto, Kyoto 606-8507, Japan
- 4Department of Neurosurgery, Koseikai Takeda Hospital, Kyoto, Kyoto 600-8558, Japan
- 5Human Genome Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108L8639, Japan
- 6Innovation Center for Health Promotion, Hirosaki University, Hirosaki, Aomori 036L8562, Japan
- 7Department of Neurosurgery, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo 660-8550, Japan
- 8Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Kyoto 606-8501, Japan
- 9Social Health Medicine Welfare Laboratory, Public Interest Incorporated Association Kyoto Hokenkai, Kyoto, Kyoto 616-8141, Japan
- 10Human Genetics Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan
- 11Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi 474-8511, Japan
- 12Biomedical Computational Intelligence Unit, HPCL and AILDriven Drug Development Platform Division, RIKEN Center for Computational Science, Kobe, Hyogo 650L0047, Japan
- 13Moyamoya Disease Support Center, Stroke Support Center, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507, Japan
- ↵*Corresponding author: Yohei Mineharu, M.D., Ph.D., Department of Artificial Intelligence in Healthcare and Medicine, Kyoto University Graduate School of Medicine, Department of Neurosurgery, Kyoto University Graduate School of Medicine 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, JAPAN, TEL: +81-75-751-3459 FAX: +81-75-752-9501, E-mail: mineharu{at}kuhp.kyoto-u.ac.jp
Posted December 16, 2024.
Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos